Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
FACS analysis of Alpha-synuclein (GFP) on HEK293/Human Alpha-synuclein (GFP) Stable Cell Line.
HEK293/Human Alpha-synuclein (GFP) Stable Cell Line was red line, negative control HEK293 cells was grey line (QC tested).
Immobilized Human Alpha-Synuclein (A53T), His Tag (Cat. No. ALN-H51H5) at 1 μg/mL (100 μL/well) can bind Synuclein alpha/beta Monoclonal Antibody with a linear range of 1-31 ng/mL (QC tested).
The purity of Human Alpha-Synuclein (E46K), Tag Free (Cat. No. ALN-H5117) is more than 95% and the molecular weight of this protein is around 13-20 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Syneuro (Indus Biotech) | Clinical | Indus Biotech Pvt Ltd | Parkinson Disease | Details | |
Exidavnemab | PD-0805; BAN-0805; BBV-0805; ABBV-0805; PR-1808164 | Abbvie Inc | Details | ||
ACI-7104 | ACI-7104 | Phase 1 Clinical | Ac Immune Sa | Parkinson Disease | Details |
Buntanetap | ANVS-405; ANVS-401 | Phase 3 Clinical | Raptor Pharmaceutical | Down Syndrome; Chronic Traumatic Encephalopathy; Alzheimer Disease; Cognitive Dysfunction; Parkinson Disease; Frontotemporal Dementia | Details |
Kenterin | ENT-01; kenterin; Enterin-01 | Phase 2 Clinical | Enterin Inc | Constipation; Parkinson Disease; Dementia | Details |
UB-312 | UB-312 | Phase 1 Clinical | United Neuroscience Ltd | Parkinsonian Disorders; Parkinson Disease | Details |
Lu AF-82422 (Lundbeck A/S) | Lu AF-82422; Lu AF82422; Lu-AF82422 | Phase 2 Clinical | H. Lundbeck A/S, Genmab A/S | Parkinson Disease; Multiple System Atrophy | Details |
[18F]UCB-2897 | Phase 1 Clinical | Invicro Llc | Parkinsonian Disorders; Parkinson Disease; Multiple System Atrophy | Details | |
Prasinezumab | PRX-002; RG-7935; NEOD-002; RO-7046015 | Phase 2 Clinical | Prothena | Parkinson Disease | Details |
PBT-434 | PBT-434; ATH-434 | Phase 2 Clinical | Prana Biotechnology Ltd | Multiple System Atrophy | Details |
Emrusolmin | Anle-138b; TEV-56286 | Phase 1 Clinical | Modag Gmbh | Parkinson Disease | Details |
ACI-3847 | ACI-3847; 18F-ACI-3847 | Phase 1 Clinical | Ac Immune Sa, Biogen Inc | Parkinson Disease; Neurodegenerative Diseases | Details |
MEDI-1341 | MEDI-1341; TAK- 341 | Phase 2 Clinical | Astrazeneca Pharmaceutical Co Ltd, Takeda Pharmaceutical Co Ltd | Parkinson Disease; Multiple System Atrophy | Details |
ION-464 | BIIB-101; IONIS-BIIB6 Rx; ION-464 | Phase 1 Clinical | Ionis Pharmaceuticals Inc | Multiple System Atrophy | Details |
UCB-0599 | UCB-1332; NPT200-11; UCB-0599 | Phase 2 Clinical | Neuropore Therapies Inc, Novartis Ag | Parkinson Disease | Details |
UCB-7853 | UCB-7853 | Phase 1 Clinical | Ucb Biopharma Srl | Parkinson Disease | Details |
This web search service is supported by Google Inc.